Inhibitor of apoptosis proteins are regulated by tumour necrosis factor‐α in malignant pleural mesothelioma
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Inhibitor of apoptosis proteins (IAPs) are overexpressed by most neoplasms and promote tumour cell survival after a wide variety of apoptotic stimuli elicited via intrinsic (ie mitochondrial) and extrinsic (ie death receptor) pathways. It has previously been reported that one of these proteins, IAP‐1(MIHC/cIAP2), is overexpressed in malignant pleural mesothelioma (MPM) and is responsible for a large degree of the resistance of cultured MPM cells to cisplatin. Subsequent analysis in a larger number of human tumours revealed that additional IAPs (eg IAP‐2/MIHB/cIAP1, livin/ML‐IAP/KIAP, survivin, and XIAP/MIHA/hILP) are also overexpressed in MPM and, with the exception of IAP‐2, have expression patterns that correlate with prognosis. In the present study, potential regulatory mechanisms of IAP genes in MPM were investigated and it was found that tumour necrosis factor‐alpha (TNF‐α) can increase mRNA and protein levels of IAP‐1, IAP‐2, and XIAP, but not livin or survivin in MPM cell lines (n = 4). It was also found that IAP gene expression levels are increased concomitantly with translocation to the nucleus of the TNF‐responsive transcription factor NF‐κB. Co‐incubation of MPM cells with TNF‐α and pyrrolidine dithiocarbamate (PDTC), an NF‐κB inhibitor, prevented TNF‐mediated up‐regulation of IAP gene expression levels. In survival studies, TNF‐α was not toxic to MPM cells at any concentration examined. However, MPM cells exposed to TNF‐α were twice as resistant to cisplatin in dose response survival assays compared with unstimulated controls and were found to have a significantly greater fraction of surviving cells at multiple cisplatin concentrations (p < 0.0087). Finally, it was found that levels of circulating TNF‐α were statistically significantly (p = 0.031) (median 312.5 pg/ml) higher in MPM patients (n = 6) prior to surgical tumour debulking compared with those after surgery (median 0 pg/ml). These results when combined with previous observations by our laboratory and others strongly suggest that IAPs act synergistically with TNF family members to promote survival of MPM tumour cells after exposure to cisplatin and possibly other chemotherapeutic drugs. Copyright © 2007 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vogelzang, N. J., Rusthoven, J. J., Symanowski, J., Denham, C., Kaukel, E., Ruffie, P., Gatzemeier, U., Boyer, M., Emri, S., Manegold, C., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.11.136 · Cited by 3,060
Signalling pathways of the TNF superfamily: a double-edged sword
Aggarwal, B. B. (2003) · Nature Reviews Immunology · doi:10.1038/nri1184 · Cited by 2,793 · cited 4×
“However, deletion of either receptor abrogates most TNF-related functions, suggesting that receptor cross-talk is necessary for physiological function [35].”
BackgroundInfluentialIAP proteins: blocking the road to death's door
Salvesen, G. S., & Duckett, C. S. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm830 · Cited by 1,756 · cited 14×
“In other studies, we have found that multiple IAPs are up-regulated in MPM tumours, several of which have expression patterns that correlate with patient prognosis [18].”
BackgroundInfluentialChu, Z.-L., McKinsey, T. A., Liu, L., Gentry, J. J., Malim, M. H., & Ballard, D. W. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.19.10057 · Cited by 872 · cited 2×
“IAP-1, IAP-2, and XIAP can be transcriptionally up-regulated by TNF-α via activation of NF-κB [8,9] and IAPs can also positively affect their own transcription [26], thus resulting in a positive feedback loop.”
BackgroundRheinwald, J. G., Hahn, W. C., Ramsey, M. R., Wu, J. Y., Guo, Z., Tsao, H., De Luca, M., Catricalà, C., & O'Toole, K. M. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.14.5157-5172.2002 · Cited by 338 · cited 5×
“HM3 cells were grown in a previously optimized [21,22] proliferative permissive medium of M199/MCDB105 (1 : 1, v/v), 15% newborn calf serum, 0.”
MethodInfluential
Cited by
Tumour necrosis factor and cancer
Balkwill, F. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2628 · Cited by 1,915
Transcriptome sequencing of malignant pleural mesothelioma tumors
Sugarbaker, D. J., Richards, W. G., Gordon, G. J., Dong, L., De Rienzo, A., Maulik, G., Glickman, J. N., Chirieac, L. R., Hartman, M.-L., Taillon, B. E., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0712399105 · Cited by 155
“Expression profiling with microarrays has supported the general role of inflammation in MPM etiology and has provided molecular markers for diagnosis and prognosis (17).”
BackgroundSelf-citationBharadwaj, U., Marin-Muller, C., Li, M., Chen, C., & Yao, Q. (2011) · Molecular Cancer · doi:10.1186/1476-4598-10-106 · Cited by 151
“The ability of normal mesothelial and mesothelioma cells [36-38] to survive/proliferate in presence of TNF-a is intriguing.”
BackgroundOhara, Y., Chew, S. H., Misawa, N., Wang, S., Somiya, D., Nakamura, K., Kajiyama, H., Kikkawa, F., Tsuyuki, Y., Jiang, L., et al. (2018) · Oncotarget · doi:10.18632/oncotarget.24892 · Cited by 44
“Inhibitor of apoptosis (IAP) family proteins are also overexpressed in mesothelioma [42] and may regulate drug resistance [43] or pharmacological effects of chemotherapeutic drugs [43–45].”
Skowron, M. A., Eul, K., Stephan, A., Ludwig, G. F., Wakileh, G. A., Bister, A., Söhngen, C., Raba, K., Petzsch, P., Poschmann, G., et al. (2022) · Molecular Oncology · doi:10.1002/1878-0261.13282 · Cited by 20
Metadata
- Authors
- Gordon, G., Mani, M., Mukhopadhyay, L., Dong, L., Yeap, B., Sugarbaker, D., & Bueno, R.
- Venue
- The Journal of Pathology
- Publisher
- Wiley
- Published
- 2007-01-25
- Volume
- 211
- Issue
- 4
- Pages
- 439-446
- ISSN
- 0022-3417 (ISSN-L)
- 1096-9896
- OpenAlex
- W2012095464
- Cited by
- 68
- References
- 5
- FWCI
- 2.87
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Inhibitor of apoptosis proteins are regulated by tumour necrosis factor‐α in malignant pleural mesothelioma. https://app.cochat.ai/papers/10.1002/path.2120
- The paper
- Gordon, G., Mani, M., Mukhopadhyay, L., Dong, L., Yeap, B., Sugarbaker, D., & Bueno, R. (2007). Inhibitor of apoptosis proteins are regulated by tumour necrosis factor‐α in malignant pleural mesothelioma. The Journal of Pathology. https://doi.org/10.1002/path.2120
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.